Лечение и прогноз больных переходноклеточным раком мочевого пузыря с метастазами в регионарные лимфоузлы
https://doi.org/10.17650/1726-9776-2007-3-4-30-35
Об авторах
Р. В. ХабаловРоссия
Отделение урологии
Москва
В. Б. Матвеев
Россия
Отделение урологии
Москва
М. И. Волкова
Россия
Отделение урологии
Москва
Д. А. Носов
Россия
Отделение урологии
Москва
Список литературы
1. Paik M.L., Scolieri M.J., Brown S.L. et al. Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy. J Urol 2000;163(6):1693—6.
2. Jaske G., Algaba F., Fossa S. et al. EAU guidelines on bladder cancer. Muscle invasive and metastatic. 2004.
3. Fleishmann A., Thalmann G.N., Markwalder R. et al. Prognostic implications of extracapsular extension of pelvic lymph node metastases in uroyhelial carcinoma of the bladder. Am J Surg Pathol 2005;29(1):89—95.
4. Herr H.W. Superiority of ratio based lymph node staging for bladder cancer. J Urol 2003;169(3):943—5.
5. Bajorin D.F., Dodd P.M., Mazumdar M. et al. Long-term survival in metastatic transitional cell carcinoma and prognostic factors predicting outcome of therapy. J Clin Oncol 1999;17:3173—81.
6. Saxman S.B., Propert K.J., Einhorn L.H. et al. Long-term follow-up of a phase III intergroup study of cisplatine alone or in combination with VAC in patients with metastatic urotelial carcinoma. J Clin Oncol 1997;15:2564—9.
7. Kerr W.S., Colby F.H. Pelvic lymph node dissection and total cystectomy in the treatment of carcinoma of the bladder. J Urol 1950:63:842—51.
8. Whitmore W., Marshall V. Radical total cystectomy for cancer of the bladder. J Urol; 1962:853—68.
9. Herr H.W., Donat S.M. Invasive Bladder Cancer. In: Genitourinary Oncology. 3rd ed. N.J. Vogelzang, P.T. Scarding, W.U. Shipley, D.S. Coffey (eds). Lippincott, Williams and Wilkins; 2005. p. 467—74.
10. Dalbagni G., Genega E., Herr H.W. et al. Cystectomy for bladder cancer: a contemporary series. J Urol 2001;165:1111—6.
11. Mills R.D., Turner W.H., Fleishmann A. et al. Pelvic lymph node metastases: outcome in 83 patients aftr radical cystectomy and pelvic lymphadenectomy. J Urol 2001;166:19—23.
12. Stein J.P., Cai J., Groshen S., Skinner D.G. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density. J Urol 2003;170(1):35—41.
13. Sherif A., Rintala E., Mestad O. et al. Neoadjuvant cisplatin-methotrexate chemotherapy for invasive bladder cancer Nordic cystectomy trial 2. Scand J Urol Nephrol 2002; 36(6):419—25.
14. International collaboration of Trialists. Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomized controlled trial. Lancet 1999;354(9178):533—40.
15. Leissner J., Ghoneim M.A., Abol-Enein H. et al. Extended radical lymphadenectomy in patients with urothelial bladder cancer:results of a prospective multicenter study. J Urol 2004;171:139—44.
16. Poulsen J., Krarup T. Pelvic lymphadenectomy (staging) in patients with bladder cancer: laparoscopic versus open approuch. Scand J Urol Nephrol Suppl 1995;172:19—21.
17. Wiesner C., Pfitzenmaier J., Faldum A. et al. Lymph node metastases in non-muscle invasive bladder cancer are correlated with the number of transurethral resections and tumour upstaging at radical cystectomy. BJU Int 2005;95(3):301—5.
18. Vieveg J., Gschwend J.E., Herr H.W. Pelvic lymph node dissection can be curative in patients with node positive bladder cancer. J Urol 1999;161:449—54.
19. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis. Lancet 2003;361:1927—34.
20. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Eur Urol 2005;48(2):189-99; discussion 199-201. Epub 2005 Apr 25.
21. Kassouf W., Leibovici D., Munsell M.F. et al. Evaluation of the relevance of lymph node density in a contemporary series of patients undergoing radical cystectomy. J Urol 2006;176(1):53—7.
22. Stockle M., Meyenburg W., Wellek S. et al. Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience. J Urol 1995;153(1):47—52.
23. Simms M.S., Mann G., Kockelbergh R.C., Mellon J.K. The management of lymph node metastasis from bladder cancer. Eur J Surg Oncol 2005;31(4):348—56.
Рецензия
Для цитирования:
Хабалов Р.В., Матвеев В.Б., Волкова М.И., Носов Д.А. Лечение и прогноз больных переходноклеточным раком мочевого пузыря с метастазами в регионарные лимфоузлы. Онкоурология. 2007;3(4):30-35. https://doi.org/10.17650/1726-9776-2007-3-4-30-35
For citation:
Khabalov R.V., Matveev V.B., Volkova M.I., Nosov D.A. Treatment and prognosis in patients with transitional cell carcinoma of the urinary bladder metastasizing to regional lymph nodes. Cancer Urology. 2007;3(4):30-35. (In Russ.) https://doi.org/10.17650/1726-9776-2007-3-4-30-35